Fauci vs Kardashian: the public prefers health tips from experts
Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.
Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.
Interview and article by Christine Clark Dr Peter English, a consultant in communicable disease control describes the UK HPV vaccination strategy and the associated issues. Dr Peter English,… read more.
Article written by Gary Finnegan. New data released by Australian researchers reveals the impact of the COVID-19 lockdown period on aeromedical retrievals in rural and remote regions. Researchers… read more.
Interview and article by Christine Clark Cervical cancer accounts for about 850 cancer deaths in the UK every year – more than two every day – and yet… read more.
Article written by Gary Finnegan. Face masks likely played a role in reducing the spread of SARS-CoV-2 in Italy during the first half of 2020, according to a… read more.
Ocugen announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase III study of Covaxin, a whole virion inactivated COVID-19… read more.
AstraZeneca and FibroGen, Inc. announced that the FDA informed FibroGen that it will convene a meeting of the Cardiovascular and Renal Drugs Advisory Committee to review the new… read more.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King’s College London has been made available to advance research on… read more.
Oncopeptides AB (publ) – announced that the FDA, has approved Pepaxto (melphalan flufenamide, also known as melflufen), in combination with dexamethasone, for the treatment of adult patients with… read more.
The centre is part of the German Federal Institute for Risk Assessment (BfR). With the help of microscopy and artificial intelligence, the “E-Morph” test reliably identifies substances that… read more.
Merck announced the company is voluntarily withdrawing the U.S. indication for Keytruda (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression… read more.
Heart problems cause disturbed gene activity in the brain’s memory center, from which cognitive deficits arise.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.